Our chemogenetic data being in complete adequation with the pharmacological data, the present study further indicates that targeting Raphe nuclei 5-HT1A autoreceptors with selective and potent agonists might represent an innovative pharmacotherapeutic strategy to combat alcohol abuse. The gene discussed is HTR1A; the disease is alcohol abuse.